Annual Cash & Cash Equivalents
$38.38 M
NaN%
December 1, 2023
Summary
- As of February 8, 2025, CAMP annual cash & cash equivalents is $38.38 million
- During the last 3 years, CAMP annual cash & cash equivalents has fallen by -$56.24 million (-59.44%).
- CAMP annual cash & cash equivalents is now -85.04% below its all-time high of $256.50 million, reached on February 28, 2019.
Performance
CAMP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$2.53 M
-$10.08 M-79.95%
September 1, 2024
Summary
- As of February 8, 2025, CAMP quarterly cash and cash equivalents is $2.53 million, with the most recent change of -$10.08 million (-79.95%) on September 1, 2024.
- Over the past year, CAMP quarterly cash and cash equivalents has dropped by -$36.03 million (-93.44%).
- CAMP quarterly cash and cash equivalents is now -99.08% below its all-time high of $273.97 million, reached on August 31, 2018.
Performance
CAMP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CAMP Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.9% | -93.4% |
| 3 y3 years | -59.4% | -94.7% |
| 5 y5 years | -85.0% | -97.3% |
CAMP Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -59.4% | at low | -97.2% | at low |
| 5 y | 5-year | -85.0% | at low | -97.7% | at low |
| alltime | all time | -85.0% | >+9999.0% | -99.1% | +2428.0% |
CAMP4 Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.53 M(-79.9%) |
| Jun 2024 | - | $12.61 M(-67.2%) |
| Dec 2023 | $38.38 M(-53.9%) | $38.38 M(+0.6%) |
| Nov 2023 | - | $38.17 M(-1.0%) |
| Aug 2023 | - | $38.56 M(+10.3%) |
| May 2023 | - | $34.96 M(-16.6%) |
| Feb 2023 | - | $41.93 M(-6.6%) |
| Dec 2022 | $83.19 M(+5.0%) | - |
| Nov 2022 | - | $44.91 M(-5.9%) |
| Aug 2022 | - | $47.72 M(-19.2%) |
| May 2022 | - | $59.04 M(-25.5%) |
| Feb 2022 | $79.22 M(-16.3%) | $79.22 M(-13.1%) |
| Nov 2021 | - | $91.11 M(-9.8%) |
| Aug 2021 | - | $101.05 M(+5.1%) |
| May 2021 | - | $96.18 M(+1.6%) |
| Feb 2021 | $94.62 M(-11.9%) | $94.62 M(+3.2%) |
| Nov 2020 | - | $91.69 M(-14.4%) |
| Aug 2020 | - | $107.14 M(+3.0%) |
| May 2020 | - | $104.07 M(-3.1%) |
| Feb 2020 | $107.40 M(-58.1%) | $107.40 M(+5.7%) |
| Nov 2019 | - | $101.63 M(-47.5%) |
| Aug 2019 | - | $193.68 M(+1.8%) |
| May 2019 | - | $190.30 M(-25.8%) |
| Feb 2019 | $256.50 M(+93.4%) | $256.50 M(-5.6%) |
| Nov 2018 | - | $271.61 M(-0.9%) |
| Aug 2018 | - | $273.97 M(+61.6%) |
| May 2018 | - | $169.51 M(+27.8%) |
| Feb 2018 | $132.60 M(+41.5%) | $132.60 M(-4.0%) |
| Nov 2017 | - | $138.09 M(+9.0%) |
| Aug 2017 | - | $126.64 M(+16.5%) |
| May 2017 | - | $108.69 M(+16.0%) |
| Feb 2017 | $93.71 M(-32.8%) | $93.71 M(+24.7%) |
| Nov 2016 | - | $75.15 M(-20.7%) |
| Aug 2016 | - | $94.70 M(+40.3%) |
| May 2016 | - | $67.49 M(-51.6%) |
| Feb 2016 | $139.39 M(+307.8%) | $139.39 M(+30.7%) |
| Nov 2015 | - | $106.68 M(+6.6%) |
| Aug 2015 | - | $100.10 M(-14.0%) |
| May 2015 | - | $116.43 M(+240.6%) |
| Feb 2015 | $34.18 M(+77.7%) | $34.18 M(+42.6%) |
| Nov 2014 | - | $23.96 M(+2.9%) |
| Aug 2014 | - | $23.30 M(+5.6%) |
| May 2014 | - | $22.05 M(+14.7%) |
| Feb 2014 | $19.23 M(-69.5%) | $19.23 M(-38.2%) |
| Nov 2013 | - | $31.11 M(+4.8%) |
| Aug 2013 | - | $29.68 M(+21.2%) |
| May 2013 | - | $24.50 M(-61.2%) |
| Feb 2013 | $63.10 M(+1026.6%) | $63.10 M(+365.3%) |
| Nov 2012 | - | $13.56 M(+32.5%) |
| Aug 2012 | - | $10.23 M(+39.9%) |
| May 2012 | - | $7.32 M(+30.6%) |
| Feb 2012 | $5.60 M(+32.1%) | $5.60 M(+27.5%) |
| Nov 2011 | - | $4.39 M(+3.2%) |
| Aug 2011 | - | $4.26 M(-1.8%) |
| May 2011 | - | $4.34 M(+2.2%) |
| Feb 2011 | $4.24 M(+42.0%) | $4.24 M(+4.7%) |
| Aug 2010 | - | $4.05 M(+0.6%) |
| May 2010 | - | $4.03 M(+34.8%) |
| Feb 2010 | $2.99 M(-56.8%) | $2.99 M(-33.9%) |
| Nov 2009 | - | $4.51 M(+2.6%) |
| Aug 2009 | - | $4.40 M(+0.4%) |
| May 2009 | - | $4.38 M(-36.6%) |
| Feb 2009 | $6.91 M(+4.9%) | $6.91 M(+21.2%) |
| Nov 2008 | - | $5.70 M(+21.4%) |
| Aug 2008 | - | $4.70 M(-34.9%) |
| May 2008 | - | $7.21 M(+9.5%) |
| Feb 2008 | $6.59 M(-82.4%) | $6.59 M(+30.8%) |
| Nov 2007 | - | $5.04 M(-39.8%) |
| Aug 2007 | - | $8.37 M(-24.9%) |
| May 2007 | - | $11.14 M(-70.3%) |
| Feb 2007 | $37.54 M | $37.54 M(+12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2006 | - | $33.28 M(+30.6%) |
| Aug 2006 | - | $25.48 M(-17.2%) |
| May 2006 | - | $30.78 M(-32.8%) |
| Feb 2006 | $45.78 M(+47.5%) | $45.78 M(+19.8%) |
| Nov 2005 | - | $38.20 M(+15.4%) |
| Aug 2005 | - | $33.10 M(+13.4%) |
| May 2005 | - | $29.19 M(-6.0%) |
| Feb 2005 | $31.05 M(+35.7%) | $31.05 M(+17.0%) |
| Nov 2004 | - | $26.53 M(+5.0%) |
| Aug 2004 | - | $25.27 M(+6.9%) |
| May 2004 | - | $23.64 M(+3.3%) |
| Feb 2004 | $22.89 M(+4.3%) | $22.89 M(-9.5%) |
| Nov 2003 | - | $25.29 M(+9.6%) |
| Aug 2003 | - | $23.08 M(+5.4%) |
| May 2003 | - | $21.90 M(-0.2%) |
| Feb 2003 | $21.95 M(-5.2%) | $21.95 M(-18.9%) |
| Nov 2002 | - | $27.05 M(+15.1%) |
| Aug 2002 | - | $23.51 M(+19.9%) |
| May 2002 | - | $19.60 M(-15.3%) |
| Feb 2002 | $23.16 M(+136.8%) | $23.16 M(+16.9%) |
| Nov 2001 | - | $19.81 M(+9.9%) |
| Aug 2001 | - | $18.02 M(+47.2%) |
| May 2001 | - | $12.24 M(+25.2%) |
| Feb 2001 | $9.78 M(+250.3%) | $9.78 M(+58.4%) |
| Nov 2000 | - | $6.17 M(-25.8%) |
| Aug 2000 | - | $8.32 M(+70.3%) |
| May 2000 | - | $4.89 M(+75.1%) |
| Feb 2000 | $2.79 M(-70.0%) | $2.79 M(-33.5%) |
| Nov 1999 | - | $4.20 M(-41.7%) |
| Aug 1999 | - | $7.20 M(+14.3%) |
| May 1999 | - | $6.30 M(-32.3%) |
| Feb 1999 | $9.30 M(+111.4%) | $9.30 M(+20.8%) |
| Nov 1998 | - | $7.70 M(+30.5%) |
| Aug 1998 | - | $5.90 M(+15.7%) |
| May 1998 | - | $5.10 M(+15.9%) |
| Feb 1998 | $4.40 M(+37.5%) | $4.40 M(+29.4%) |
| Nov 1997 | - | $3.40 M(+36.0%) |
| Aug 1997 | - | $2.50 M(-21.9%) |
| May 1997 | - | $3.20 M(0.0%) |
| Feb 1997 | $3.20 M(-72.4%) | $3.20 M(+52.4%) |
| Nov 1996 | - | $2.10 M(-46.2%) |
| Aug 1996 | - | $3.90 M(-40.0%) |
| May 1996 | - | $6.50 M(-44.0%) |
| Feb 1996 | $11.60 M(+582.4%) | $11.60 M(+33.3%) |
| Nov 1995 | - | $8.70 M(+24.3%) |
| Aug 1995 | - | $7.00 M(+311.8%) |
| May 1995 | - | $1.70 M(0.0%) |
| Feb 1995 | $1.70 M(+142.9%) | $1.70 M(-10.5%) |
| Nov 1994 | - | $1.90 M(+111.1%) |
| Aug 1994 | - | $900.00 K(+50.0%) |
| May 1994 | - | $600.00 K(-14.3%) |
| Feb 1994 | $700.00 K(-12.5%) | $700.00 K(+40.0%) |
| Nov 1993 | - | $500.00 K(+25.0%) |
| Aug 1993 | - | $400.00 K(-50.0%) |
| Feb 1993 | $800.00 K(+60.0%) | $800.00 K(+700.0%) |
| Nov 1992 | - | $100.00 K(-75.0%) |
| Aug 1992 | - | $400.00 K(+100.0%) |
| May 1992 | - | $200.00 K(-60.0%) |
| Feb 1992 | $500.00 K(+400.0%) | $500.00 K(+400.0%) |
| Aug 1991 | - | $100.00 K(0.0%) |
| May 1991 | - | $100.00 K(0.0%) |
| Feb 1991 | $100.00 K(0.0%) | $100.00 K(0.0%) |
| Nov 1990 | - | $100.00 K(-50.0%) |
| Aug 1990 | - | $200.00 K(+100.0%) |
| Feb 1990 | $100.00 K(0.0%) | $100.00 K(0.0%) |
| Feb 1989 | $100.00 K(-50.0%) | $100.00 K(-50.0%) |
| Feb 1988 | $200.00 K(-66.7%) | $200.00 K(-66.7%) |
| Feb 1987 | $600.00 K(+500.0%) | $600.00 K(+500.0%) |
| Feb 1986 | $100.00 K(-75.0%) | $100.00 K(-75.0%) |
| Feb 1985 | $400.00 K(-92.7%) | $400.00 K |
| Feb 1984 | $5.50 M | - |
FAQ
- What is CAMP4 Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CAMP4 Therapeutics?
- What is CAMP4 Therapeutics annual cash & cash equivalents year-on-year change?
- What is CAMP4 Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CAMP4 Therapeutics?
- What is CAMP4 Therapeutics quarterly cash and cash equivalents year-on-year change?
What is CAMP4 Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CAMP is $38.38 M
What is the all time high annual cash & cash equivalents for CAMP4 Therapeutics?
CAMP4 Therapeutics all-time high annual cash & cash equivalents is $256.50 M
What is CAMP4 Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CAMP annual cash & cash equivalents has changed by -$44.81 M (-53.86%)
What is CAMP4 Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CAMP is $2.53 M
What is the all time high quarterly cash and cash equivalents for CAMP4 Therapeutics?
CAMP4 Therapeutics all-time high quarterly cash and cash equivalents is $273.97 M
What is CAMP4 Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CAMP quarterly cash and cash equivalents has changed by -$36.03 M (-93.44%)